Related Experiment Video
Updated: Mar 14, 2026

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation
Published on: November 10, 2023
Airflow Obstruction in Post-tuberculosis Lung Disease: A 5-year Prospective Cohort Study
Zi Kang Sheng1, Wen Li Cao2, Hong Ling Chu3
1Department of Respiratory and Critical Care Medicine, Peking University Third Hospital; Chronic Airway Diseases Research Center, Peking University Health Science Center; Beijing 100191, China.
Post tuberculosis lung disease (PTLD) can lead to airflow obstruction, even in younger, non-smoking individuals. Long-term lung function monitoring is crucial for TB survivors to detect and manage conditions like TB-COPD.
Area of Science:
- Pulmonology
- Infectious Diseases
- Radiology
Background:
- Post tuberculosis lung disease (PTLD) encompasses conditions like tuberculosis-associated chronic obstructive pulmonary disease (TB-COPD).
- The long-term clinical trajectory and risk factors for airflow obstruction in PTLD are not fully understood.
Purpose of the Study:
- To evaluate longitudinal changes in lung function over five years in patients treated for active pulmonary tuberculosis.
- To identify predictors of airflow obstruction in this cohort.
Main Methods:
- A cohort of patients with active pulmonary TB was followed longitudinally.
- Assessments included lung function tests and chest CT scans at treatment completion and five years post-treatment.
Main Results:
- Airflow obstruction increased from 13.2% at baseline to 17.0% at 5-year follow-up.
- Significant decline in mean FEV1/FVC ratio observed over five years.
- Chest CT findings in obstructed patients were consistent with TB-COPD, including air trapping, even in younger, non-smoking individuals.
Conclusions:
- Airflow obstruction is a significant long-term complication of pulmonary TB.
- The development and persistence of obstruction, particularly TB-COPD phenotype, highlight the need for extended follow-up.
- Routine lung function assessment is recommended for TB survivors.
More Related Videos
10:10A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
Published on: October 5, 2015
07:21Processing of Bronchoalveolar Lavage Fluid and Matched Blood for Alveolar Macrophage and CD4+ T-cell Immunophenotyping and HIV Reservoir Assessment
Published on: June 23, 2019
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Other Pulmonary Disorders
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories: